Clinical Trial Update: Rivaroxaban in Bariatric Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating rivaroxaban for venous thromboembolism prophylaxis in bariatric surgery patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Prophylaxis of Venous Thromboembolism | Phase 1 | Status: COMPLETED